Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayle M Wittenberg

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
CNS Drugs|February 4, 2021
Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor AntagonistsDavid M Kern, M Soledad Cepeda, Christopher M Flores, et al.
Nature Reviews. Drug Discovery|January 18, 2022
Immune targets for therapeutic development in depression: towards precision medicineWayne C Drevets, Gayle M Wittenberg, Edward T Bullmore, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 9, 2016
Clinical Relevance of Sleep Duration: Results from a Cross-Sectional Analysis Using NHANESM Soledad Cepeda, Paul Stang, Clair Blacketer, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|October 27, 2010
EDAR: an efficient error detection and removal algorithm for next generation sequencing dataXiaohong Zhao, Lance E Palmer, Randall Bolanos, et al.
Biological Psychiatry|July 13, 2020
Major Depressive Disorder Is Associated With Differential Expression of Innate Immune and Neutrophil-Related Gene Networks in Peripheral Blood: A Quantitative Review of Whole-Genome Transcriptional Data From Case-Control StudiesGayle M Wittenberg, Jon Greene, Petra E Vértes, et al.
Psychiatric Research and Clinical Practice|September 14, 2022
Revealing Unknown Benefits of Existing Medications to Aid the Discovery of New Treatments for Post-Traumatic Stress DisorderDavid M Kern, Rachel E Teneralli, Christopher M Flores, et al.
European Journal of Neurology|August 12, 2024
Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementiaGazi Saadmaan, Anette Hall, Tiia Ngandu, et al.
Brain, Behavior, and Immunity|July 6, 2017
The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's diseaseYu Sun, Dai Wang, Giacomo Salvadore, et al.
Biological Psychiatry|August 30, 2016
Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression ProfilesRosemary C Bagot, Hannah M Cates, Immanuel Purushothaman, et al.
Molecular Psychiatry|August 21, 2019
Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disordersGayle M Wittenberg, Annie Stylianou, Yun Zhang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
CNS Drugs|February 4, 2021
Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor AntagonistsDavid M Kern, M Soledad Cepeda, Christopher M Flores, et al.
Nature Reviews. Drug Discovery|January 18, 2022
Immune targets for therapeutic development in depression: towards precision medicineWayne C Drevets, Gayle M Wittenberg, Edward T Bullmore, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 9, 2016
Clinical Relevance of Sleep Duration: Results from a Cross-Sectional Analysis Using NHANESM Soledad Cepeda, Paul Stang, Clair Blacketer, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|October 27, 2010
EDAR: an efficient error detection and removal algorithm for next generation sequencing dataXiaohong Zhao, Lance E Palmer, Randall Bolanos, et al.
Biological Psychiatry|July 13, 2020
Major Depressive Disorder Is Associated With Differential Expression of Innate Immune and Neutrophil-Related Gene Networks in Peripheral Blood: A Quantitative Review of Whole-Genome Transcriptional Data From Case-Control StudiesGayle M Wittenberg, Jon Greene, Petra E Vértes, et al.
Psychiatric Research and Clinical Practice|September 14, 2022
Revealing Unknown Benefits of Existing Medications to Aid the Discovery of New Treatments for Post-Traumatic Stress DisorderDavid M Kern, Rachel E Teneralli, Christopher M Flores, et al.
European Journal of Neurology|August 12, 2024
Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementiaGazi Saadmaan, Anette Hall, Tiia Ngandu, et al.
Brain, Behavior, and Immunity|July 6, 2017
The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's diseaseYu Sun, Dai Wang, Giacomo Salvadore, et al.
Biological Psychiatry|August 30, 2016
Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression ProfilesRosemary C Bagot, Hannah M Cates, Immanuel Purushothaman, et al.
Molecular Psychiatry|August 21, 2019
Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disordersGayle M Wittenberg, Annie Stylianou, Yun Zhang, et al.
Pageof 3